avanafil

Related by string. Avanafil * * avanafil potentially . avanafil PDE5 inhibitor *

Related by context. All words. (Click for frequent words.) 66 QNEXA 66 Ophena TM 65 Menerba 65 Capesaris 65 Avanafil 65 PDE5 inhibitor 64 tezampanel 63 Clonicel 63 trospium 63 ALGRX 63 alvimopan 63 Naproxcinod 62 bremelanotide 62 Phenoptin 62 Zoraxel 62 LEVADEX 62 desvenlafaxine succinate 62 PRX # 62 eltrombopag 61 AFRESA 61 LibiGel ® 61 Gabapentin GR 61 Corlux 61 Androxal 61 Phase 2a trial 61 ALKS 61 teriflunomide 61 anidulafungin 61 SILENOR TM 61 BEMA Buprenorphine 61 vilazodone 61 DDP# 61 Anturol TM 60 PRT# 60 LibiGel 60 torezolid phosphate 60 cangrelor 60 INCB# [001] 60 Phase IIb trials 60 pramlintide 60 Genz # 60 bicifadine 60 avanafil PDE5 inhibitor 60 maximally tolerated dose 60 RSD# 60 Nasulin 60 Vilazodone 60 Ranexa 60 dalbavancin 60 oral rivaroxaban 60 flibanserin 59 JANUVIA 59 phase IIa clinical 59 Afresa 59 apremilast 59 DCCR 59 VA# [002] 59 oral ridaforolimus 59 tanespimycin 59 Zerenex 59 DPP4 inhibitor 59 treprostinil 59 Phase Ib study 59 AEGR 59 R#/MEM # 59 diabetic neuropathic pain 59 INT# [002] 59 darusentan 59 Sanctura XR 59 pradefovir 59 NGX# 59 Silodosin 59 mipomersen 59 Synavive 59 forodesine 59 Acapodene 59 Ostarine 59 PDE4 inhibitor 59 lesinurad 59 mg dose 59 Reverset 59 NUVIGIL 59 Neurodex 59 Cleviprex TM clevidipine 59 ambrisentan 59 safinamide 59 Dextofisopam 59 fostamatinib 59 methylnaltrexone 59 midstage clinical 59 JAK inhibitor 59 ruxolitinib 58 elotuzumab 58 Ventavis 58 Phase IIa trial 58 Testosterone MDTS R 58 EOquin 58 Amigal 58 ADX# 58 6R BH4 58 Testosterone MDTS ® 58 NEBIDO 58 alvespimycin 58 Zelrix 58 AZILECT R 58 Jevtana 58 pivotal Phase III 58 vernakalant 58 Dyloject TM 58 tecarfarin 58 visilizumab 58 albiglutide 58 Q#IR 58 zolmitriptan 58 Phase 1b 58 phase IIa 58 Icatibant 58 dose cohort 58 Pruvel 58 oral methylnaltrexone 58 cannabinor 58 ropinirole 58 PSN# [002] 58 dapoxetine 58 Phase 2a clinical 58 aripiprazole 58 Ereska 58 Ambrisentan 58 Desmoteplase 58 PRISTIQ 58 Pimavanserin 58 MoxDuo IR 58 desvenlafaxine 58 lomitapide 58 Northera 58 #mg dose [002] 58 liprotamase 58 teduglutide 58 Triolex 58 lixisenatide 58 tasocitinib 58 Mipomersen 58 iclaprim 58 Instanyl 58 TMC# [002] 58 Plicera 58 ACTEMRA TM 58 tolvaptan 58 AVE# 58 goserelin 58 Technosphere Insulin 58 selective phosphodiesterase type 58 Amrubicin 58 darapladib 58 Phase 2b study 58 Plenaxis TM 58 Relovair 58 FROVA 58 GALNS 58 adipiplon 58 tocilizumab 58 Elocalcitol 58 zileuton 58 ozarelix 58 selective androgen receptor modulator 58 PS# [001] 57 registrational trial 57 rNAPc2 57 Elagolix 57 SILENOR 57 arzoxifene 57 dextofisopam 57 Dapagliflozin 57 Viramidine 57 NVA# 57 OvaRex ® MAb 57 exenatide LAR 57 ibandronate 57 INCB# [002] 57 MAGE A3 ASCI 57 Milnacipran 57 Nebido 57 OMNARIS Nasal Spray 57 Ozarelix 57 taranabant 57 casopitant 57 MoxDuo TM IR 57 NATRECOR R 57 registrational 57 cladribine tablets 57 Darusentan 57 Proellex TM 57 MERLIN TIMI 57 pitavastatin 57 ELND# 57 phase Ib 57 integrase inhibitor 57 Panzem R 57 RAPAFLO 57 lintuzumab 57 CAPHOSOL 57 TOCOSOL Paclitaxel 57 ALISTA 57 Trexima 57 Rezular 57 ganetespib 57 Relivar 57 APRISO 57 metaglidasen 57 lurasidone 57 fidaxomicin 57 RSD# oral 57 tasimelteon 57 LY# [003] 57 bosutinib 57 investigational drug 57 eszopiclone 57 daclizumab 57 lubiprostone 57 HCV SPRINT 57 iniparib 57 Focalin XR 57 Serada 57 Androxal ® 57 eniluracil 57 GLYX 57 HCV RESPOND 2 57 Phase IIb trial 57 Exenatide LAR 57 Bicifadine 57 AZOR 57 ancrod 57 doripenem 57 ramelteon 57 sodium glucose cotransporter 57 phase IIb clinical 57 Luramist TM 57 CORLUX 57 Qnexa 57 Increlex ® 57 Contrave# 57 davalintide 57 Onbrez Breezhaler 57 CYCLOSET 57 pomalidomide 57 Bezielle 57 clevidipine 57 APTIVUS r 57 Serdaxin 57 QVA# 57 Archexin 57 atrasentan 57 Tekamlo 57 refractory gout 57 Paxil paroxetine 57 T Pred 57 lasofoxifene 57 talactoferrin 57 faropenem 57 Androxal TM 57 budesonide foam 57 pertuzumab 57 Phase 1a clinical 57 TBC# 57 Phase III trials 57 QNEXA ® 57 Phase III 57 BAY #-# 57 custirsen 57 Phase IIB 57 MDV# 57 bazedoxifene 57 phase IIb 56 AMR# 56 azilsartan medoxomil 56 Ramoplanin 56 investigational compound 56 riociguat 56 ZEGERID Capsules 56 GAMMAGARD 56 Entereg 56 silodosin 56 SNRI 56 trastuzumab DM1 56 Adlea 56 ILLUMINATE 56 CORT # 56 ZOLINZA 56 axitinib 56 cetrorelix 56 phase IIb study 56 Pivotal Phase 56 Zemplar Capsules 56 rALLy trial 56 DURATION 56 Phase 1b trial 56 ABILIFY ® 56 KRN# 56 MNTX 56 Frova R 56 Lysteda 56 ZYFLO 56 NPSP# 56 ITAX 56 AZILECT 56 rasagiline tablets 56 Phase 2b trial 56 ONTAK 56 APF# 56 PYY #-# 56 alicaforsen enema 56 Sitagliptin 56 ORMD 56 RhuDex ® 56 Linjeta 56 tadalafil Cialis 56 GSK# [002] 56 PEG PAL 56 Ophena 56 tezampanel NGX# 56 DU #b 56 valopicitabine 56 M6G 56 Levadex 56 GRALISE 56 opioid induced bowel dysfunction 56 TELINTRA 56 #mg dose [003] 56 ACAPODENE 56 MAP# 56 subcutaneously administered 56 Firazyr 56 Raptiva ® 56 Arikace 56 elagolix 56 EDARBI 56 sapacitabine 56 vicriviroc 56 vasomotor symptoms 56 Phase IIb clinical 56 ONGLYZA 56 orBec 56 almorexant 56 Acetavance 56 PROMACTA 56 celgosivir 56 Phase #b/#a trial 56 telcagepant 56 BENICAR HCT 56 edifoligide 56 Zalbin 56 R#/MEM 56 PHX# 56 VPRIV 56 Detrol LA 56 Hypoactive Sexual Desire Disorder 56 ocrelizumab 56 Prosaptide 56 odanacatib 56 hypogonadal men 56 serotonin norepinephrine reuptake inhibitor 56 FM VP4 56 phase 2a 56 LY# [002] 56 insulin detemir 56 hepatitis C protease inhibitor 56 Phase 2b clinical 56 ARCOXIA 56 dexpramipexole 56 Phase 2a 56 Proquin XR 56 Phase 2b clinical trials 56 Ramelteon 56 BEMA TM Fentanyl 56 Traficet EN 56 degarelix 56 IDX# 56 otelixizumab 56 aplindore 56 placebo controlled clinical 56 midstage trials 56 CRx 56 ospemifene 56 Adcirca 56 selective modulator 56 bronchodilation 56 Delatestryl 56 Dasatinib 56 CCX# 56 ORENCIA R 56 baminercept 56 PC DAC Exendin 56 abiraterone acetate 56 ACOMPLIA R 56 regorafenib 56 alagebrium 56 Tamsulosin 56 sorafenib Nexavar 56 RhuDex 56 Aptivus ® 56 indiplon capsules 56 investigational oral 56 mGluR5 NAM 56 placebo controlled trials 56 BCX# 56 monotherapy 56 intranasal formulation 56 BARACLUDE R 56 oxymorphone ER 56 placebo controlled clinical trials 56 COREG CR 56 Phase Ib 56 VIAject 56 CRMD# 56 AFREZZA 56 mealtime insulin 56 naproxcinod 56 TRILIPIX 56 Degludec 56 PDE5 inhibitors 56 analgesic efficacy 56 abiraterone 56 #mg dose [001] 56 reslizumab 56 GLP1 agonist 56 evaluating tivozanib 56 Aclidinium 56 Oral NKTR 56 eprotirome 55 MIRCERA 55 LIALDA 55 ALVESCO HFA 55 ELACYT 55 Pivotal Phase III 55 EDEMA3 55 pramipexole 55 ketoprofen patch 55 LymphoStat B belimumab 55 SNT MC# 55 efficacy tolerability 55 Marqibo 55 YONDELIS 55 subcutaneous Herceptin 55 calcitonin 55 mg doses 55 pegloticase 55 lumiliximab 55 rotigotine 55 aprepitant 55 KYNAPID 55 Telbivudine 55 bifeprunox 55 Cetrorelix 55 VivaGel TM 55 Stedivaze 55 LAF# 55 Bremelanotide 55 TriRima 55 rhThrombin 55 ISENTRESS 55 SERMs 55 deforolimus 55 aleglitazar 55 aclidinium 55 guanfacine extended release 55 LCP AtorFen 55 Lodotra 55 Exforge 55 RLY# 55 ponatinib 55 MEND CABG II 55 Locteron 55 KAPVAY ™ 55 octreotide implant 55 MoxDuo 55 Laquinimod 55 Bronchitol 55 DR Cysteamine 55 atacicept 55 oral prodrug 55 REVIVE TA 55 prodrug stimulant 55 Dabigatran etexilate 55 lanthanum carbonate 55 FIRMAGON R 55 telbivudine 55 SRT# [003] 55 mecamylamine 55 Tarceva TM 55 inhaled iloprost 55 Phase IIIb clinical 55 Degarelix 55 alpha blockers 55 secondary efficacy endpoints 55 Prodarsan ® 55 RSD# iv 55 KNS # 55 Effexor venlafaxine 55 DPP4 55 NovoMix 55 AVODART 55 GFT# 55 LEXIVA r 55 antiplatelet agent 55 Frova ® 55 HuMax EGFr 55 LibiGel testosterone gel 55 Octreolin 55 Azilect ® 55 LUNESTA 55 sorafenib tablets 55 Clevudine 55 raloxifene Evista 55 PRTX 55 prucalopride 55 oxcarbazepine 55 Phase 2a clinical trials 55 LibiGel Phase III 55 Intuniv 55 BNC# 55 Xinlay 55 primary hypercholesterolemia 55 milligram dose 55 Herceptin trastuzumab 55 PREOS R 55 betrixaban 55 REMINYL ® 55 Anturol 55 lacosamide 55 zafirlukast 55 EOquin TM 55 pregabalin 55 dose titration 55 CoFactor 55 oral anticoagulant 55 Tasimelteon 55 Estorra 55 crofelemer 55 Aflibercept 55 Zyflo 55 Intermezzo R 55 Enjuvia 55 Abiraterone acetate 55 Valdoxan 55 Phase IIa trials 55 Telaprevir 55 Dapoxetine 55 balsalazide tablet 55 radezolid 55 Tyrima 55 polymerase inhibitor 55 MEND CABG 55 protease inhibitor PI 55 Prestara 55 omiganan 55 CCR5 inhibitor 55 oral deforolimus 55 sitaxsentan 55 Viprinex TM 55 EFFEXOR XR 55 Cycloset 55 PREZISTA r 55 AndroGel 55 velaglucerase alfa 55 EMEND 55 tenofovir emtricitabine 55 S/GSK# 55 Stelara 55 SCOLR Pharma 55 HuLuc# 55 Lu AA# 55 IV APAP 55 TREDAPTIVE 55 aliskiren 55 indacaterol 55 Urocidin 55 metastatic hormone refractory 55 Zenvia ™ 55 CDP# 55 Toviaz 55 exenatide 55 phase IIb trial 55 Fablyn 55 linaclotide 55 lapatinib Tykerb 55 Rebif ® 55 Dyloject 55 Zolinza 55 Diamyd ® 55 Zingo TM 55 insulin degludec 55 Femara letrozole 55 Zavesca R 55 rFIXFc 55 selegiline 55 Ocrelizumab 55 Lixivaptan 55 SCH # 55 abatacept 55 incyclinide 54 peginesatide 54 Cethromycin 54 ATPace TM 54 Solulin 54 AeroLEF TM 54 fingolimod 54 PF # [001] 54 Epanova 54 Viibryd 54 ARIKACE ™ 54 oral cladribine 54 Somatuline Depot 54 oral taxane 54 Carvedilol 54 Azedra 54 oral FTY# 54 MYDICAR 54 Hyphanox 54 Abilify aripiprazole 54 oral formulation 54 partial agonist 54 nitazoxanide 54 omacetaxine mepesuccinate 54 AGGRASTAT R 54 selective A2A adenosine receptor 54 OHR/AVR# 54 Vaprisol 54 Huntexil 54 Puricase 54 Fampridine 54 clinical pharmacology studies 54 Targretin 54 alogliptin 54 BRIM3 54 huC# DM4 54 FOLOTYN ® 54 palonosetron 54 dysmenorrhea 54 dosing cohorts 54 PEG Interferon lambda 54 ostarine 54 Tablets #mg [002] 54 Topiramate 54 budesonide MMX 54 INC# 54 insulin lispro 54 dextromethorphan quinidine 54 Rasagiline 54 Serdaxin ® 54 LIVALO 54 Multaq R 54 certolizumab 54 entecavir 54 Empatic 54 milligram doses 54 efficacy endpoint 54 SAR# [004] 54 mcg dose 54 ATL# [001] 54 Levetiracetam 54 BAL# [002] 54 ATACAND 54 vidofludimus 54 belinostat 54 iloperidone 54 Albuferon 54 icatibant 54 GOUT 54 dirucotide 54 OMAPRO 54 oral renin inhibitor 54 Fibrillex TM 54 tolerability profile 54 anti androgen 54 pseudobulbar affect PBA 54 compound INCB# 54 Factor Xa inhibitor 54 placebo controlled Phase 54 ISIS # 54 dosing cohort 54 Tyvaso 54 ixabepilone 54 alfimeprase 54 Cipralex ® 54 GRN# 54 tolevamer 54 urocortin 2 54 Linagliptin 54 naproxen esomeprazole magnesium 54 Torisel 54 RezularTM 54 Phase IIb clinical trials 54 severe hypercholesterolemia 54 XmAb# 54 ProSavin 54 Tekturna 54 SAR# [002] 54 Adentri 54 darifenacin 54 Welchol 54 toremifene 54 Sprycel dasatinib 54 virus HCV protease inhibitor 54 Alzhemed TM 54 investigational antiplatelet agent 54 pharmacokinetic studies 54 mixed dyslipidemia 54 INKP 54 Iloperidone 54 TLK# 54 montelukast 54 midstage clinical trial 54 Pegasys peginterferon alfa 2a 54 Micardis ® 54 Betaferon ® 54 CA4P 54 danoprevir 54 Diamyd R 54 Saxagliptin 54 intermittent dosing 54 Sapacitabine 54 AMEVIVE 54 GLP toxicology studies 54 TOLAMBA 54 E2F Decoy 54 peg interferon 54 ONCONASE 54 tafamidis 54 TG# [003] 54 proprietary transdermal patch 54 Mg Uk 54 CCR5 antagonist 54 Zenvia TM 54 selective serotonin reuptake inhibitor 54 Duloxetine 54 HCV NS5B polymerase 54 Serdolect ® 54 nucleotide analogue 54 RDEA# 54 bicalutamide 54 Dalbavancin 54 Vernakalant 54 EndoTAG TM -1 54 elvitegravir 54 liposomal formulation 54 NP2 Enkephalin 54 Bionovo 54 INVEGA SUSTENNA 54 rolofylline 54 Pennsaid R 54 HGS# 54 denosumab 54 Amitiza 54 Randomized Phase 54 aldosterone antagonists 54 Phase III clinical 54 LymphoStat B 54 Zenvia 54 valacyclovir 54 Exforge HCT 54 noninferiority 54 pharmacokinetic PK study 54 alfuzosin 54 ranolazine 54 lisdexamfetamine dimesylate 54 EXPAREL TM 54 HIV integrase inhibitor 54 sumatriptan 54 LEP ETU 54 Vicriviroc 54 HuMax CD# 54 pioglitazone HCl 54 anticancer compound 54 Enhanze Technology 54 Relistor 54 APTIVUS 54 FTY# fingolimod 54 PROVENGE sipuleucel T 54 bosentan 54 Oxytrex 54 Phase Ib clinical 54 PREOS 54 receptor blocker 54 Panzem R NCD 54 Vivitrex 54 SUTENT ® 54 aripiprazole Abilify 54 Omigard 54 OXi# 54 panitumumab 54 double blinded placebo 54 SinuNase TM 54 APD# 54 Tekturna HCT 54 pegylated interferon alpha 54 febuxostat 54 Zytiga 54 ZYBRESTAT 54 INVIRASE 54 acyclovir Lauriad R 54 FOSRENOL R 54 hypoactive sexual desire 54 Itopride 54 Phase IIb 54 glargine 54 asenapine 54 veltuzumab 54 Zensana 54 AERx iDMS 54 Phase IIa clinical 54 Natroba 54 Phase III Pivotal 54 Rapaflo 54 Elestrin 54 BYDUREON 54 dosing regimen 54 opioid induced 54 AGGRASTAT ® 54 PRADAXA 54 rALLy clinical trial 54 active comparator 54 Eltrombopag 54 omega interferon 54 canakinumab 54 Ketotransdel TM 54 edoxaban 54 somatostatin analog 54 PYY3 54 Promacta 54 adenosine injection 53 milnacipran 53 evaluating mipomersen 53 JAK Inhibitor 53 triptan 53 PSN# [001] 53 BZL# 53 ARB telmisartan 53 AndroGel ® 53 Ramipril 53 divalproex sodium 53 ruboxistaurin 53 TRO# 53 Victoza ® 53 TYZEKA 53 Elvitegravir 53 SUCCEED trial 53 Personalized Immunotherapy 53 Emend 53 Remodulin 53 Initiate Phase 53 CINQUIL 53 Potiga 53 CANCIDAS 53 Civacir 53 Campath alemtuzumab 53 blinded randomized placebo controlled 53 vascular disrupting agent 53 CIMZIA TM 53 schizophrenia CIAS 53 class mGluR5 inhibitor 53 brivaracetam 53 Striant 53 Testim 53 relapsed MM 53 Allovectin 7 53 direct renin inhibitor 53 Rivaroxaban 53 subcutaneous formulation 53 teriparatide 53 Alfimeprase 53 TREANDA 53 ACZ# 53 cabazitaxel 53 ThGRF 53 RAPAFLO TM 53 ASCEND HF 53 nalbuphine ER 53 pharmacokinetics pharmacodynamics 53 Phase III Clinical Trial 53 REYATAZ R 53 Kuvan 53 fenofibric acid 53 Azilect 53 Phase III placebo controlled 53 VYVANSE 53 rufinamide 53 NDA submission 53 rilonacept 53 Emselex 53 Symbyax 53 AZD# 53 ORENCIA ® 53 Pramlintide 53 ZYFLO CR 53 aclidinium bromide 53 CCR5 mAb 53 Fampridine SR 53 PrevOnco 53 ketoconazole 53 Generx 53 Zensana TM 53 orally administered 53 guanfacine 53 mapatumumab 53 Inhalation Solution 53 vernakalant hydrochloride 53 paliperidone palmitate 53 Interferon alpha 53 THALOMID 53 unblinding 53 metoprolol succinate 53 Altastaph 53 NV1FGF 53 MYDICAR ® 53 CR# vcMMAE 53 DXL# 53 Vectibix panitumumab 53 Silenor 53 RISPERDAL ® 53 crizotinib PF # 53 DEB# 53 Anthim 53 candidate XP# 53 CYT# potent vascular disrupting 53 valsartan 53 cathepsin K inhibitor 53 VIRAMUNE XR 53 AVANDIA 53 Aptivus 53 Tesetaxel 53 Lyrica pregabalin 53 atomoxetine 53 dexamethasone Decadron 53 granulated mesalamine 53 MICARDIS ® 53 AGHD 53 enoximone 53 Raltegravir 53 sunitinib malate 53 BYETTA ® 53 Aurexis 53 Betaferon R 53 LEVAQUIN ® 53 multicenter Phase 53 pegylated interferons 53 Prostate AdenoCarcinoma Treatment 53 NXL# 53 phase III isavuconazole 53 oral dosing 53 tipranavir 53 QLT# 53 urate lowering 53 anti arrhythmic 53 liraglutide 53 Phase III Clinical Trials 53 Priligy 53 orally bioavailable 53 linagliptin 53 mertansine 53 USL# 53 Omnitarg 53 Gaboxadol 53 VAPRISOL 53 Afrezza 53 carcinogenicity study 53 motesanib 53 Solzira 53 phentermine topiramate 53 Apoptone 53 vardenafil Levitra 53 relapsing remitting multiple sclerosis 53 Liraglutide 53 intravenous formulation 53 Contrave 53 Egrifta 53 Horizant 53 Keppra R 53 topiramate Topamax 53 tesofensine 53 SILENOR ™ 53 AEG# 53 piperacillin tazobactam 53 diarrhea predominant irritable 53 GSK# [001] 53 ZD# [001] 53 dacetuzumab 53 Ticagrelor 53 zalutumumab 53 maribavir 53 insulin glargine 53 Levitra vardenafil 53 CIMZIA ™ 53 vemurafenib 53 interferon beta 53 Clolar 53 JAK inhibitors 53 antiemetics 53 HGS ETR2 53 relapsed multiple myeloma

Back to home page